Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin icodec vs insulin degludec in insulin-naïve type 2 diabetes
CTR20210521Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin icodec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2021; status: completed.
02
Drugs
insulin icodec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210521.